ArticleFrontiers in neurology2026
Physical frailty and the risk of peripheral vertigo: evidence from the UK Biobank cohort.
Article in Frontiers in neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Peripheral vertigo is a common clinical condition that can substantially impair patients' balance and disrupt their daily and social activities. In some patients, symptoms may persist or recur and may be accompanied by auditory dysfunction or psychological problems, thereby imposing a considerable burden on individuals, families, and healthcare systems. Physical frailty, a prevalent clinical syndrome marked by reduced physiological reserve and increased stress vulnerability, is closely linked to various age-related functional impairments. Nevertheless, the specific association between physical frailty and peripheral vertigo risk remains unclear. This study aimed to explore this relationship using large-scale population-based data from the UK Biobank (UKB). Methods: Based on UKB data, this retrospective cohort study enrolled 489,266 participants. Baseline frailty was assessed using the validated Fried phenotype encompassing five core components. Incident peripheral vertigo was defined using ICD-10 codes H810, H811, H812, and H813 based on hospital inpatient records. Multivariable Cox proportional hazards models and restricted cubic spline analyses were used to evaluate independent associations and dose-response trends, while subgroup analyses were conducted to explore sex-based heterogeneity. Results: During a median follow-up of 13.2 years, 2,802 new peripheral vertigo cases were identified. After full covariate adjustment, pre-frailty (HR = 1.36, 95% CI: 1.26-1.48) and frailty (HR = 2.05, 95% CI: 1.77-2.37) were independently associated with increased peripheral vertigo risk. A significant linear dose-response relationship was observed, with each one-point increment in frailty score increasing vertigo risk by 24% (95% CI: 19-29%). All five frailty components were independently associated with an increased risk of peripheral vertigo (all Conclusion: Pre-frailty and physical frailty were independently and dose-dependently associated with an increased risk of incident peripheral vertigo, with all five frailty components showing significant associations with peripheral vertigo risk. The detrimental association is significantly modified by sex and more pronounced in females. This study provides novel population-based evidence supporting the potential value of frailty assessment in identifying individuals at elevated risk of peripheral vertigo, especially among females.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.